| Product Code: ETC9976890 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Spasticity Treatment Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Spasticity Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Spasticity Treatment Market - Industry Life Cycle |
3.4 United States (US) Spasticity Treatment Market - Porter's Five Forces |
3.5 United States (US) Spasticity Treatment Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.6 United States (US) Spasticity Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 United States (US) Spasticity Treatment Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 United States (US) Spasticity Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 United States (US) Spasticity Treatment Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.10 United States (US) Spasticity Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.11 United States (US) Spasticity Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 United States (US) Spasticity Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders leading to spasticity |
4.2.2 Growing awareness about spasticity treatment options |
4.2.3 Technological advancements in treatment options |
4.2.4 Rising healthcare expenditure in the United States |
4.3 Market Restraints |
4.3.1 High cost associated with spasticity treatment |
4.3.2 Limited access to specialized care for spasticity management |
4.3.3 Stringent regulatory requirements for approval of treatment options |
5 United States (US) Spasticity Treatment Market Trends |
6 United States (US) Spasticity Treatment Market, By Types |
6.1 United States (US) Spasticity Treatment Market, By Therapy |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Spasticity Treatment Market Revenues & Volume, By Therapy, 2021- 2031F |
6.1.3 United States (US) Spasticity Treatment Market Revenues & Volume, By Physical Therapy, 2021- 2031F |
6.1.4 United States (US) Spasticity Treatment Market Revenues & Volume, By Occupational Therapy, 2021- 2031F |
6.2 United States (US) Spasticity Treatment Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Spasticity Treatment Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 United States (US) Spasticity Treatment Market Revenues & Volume, By Surgery, 2021- 2031F |
6.3 United States (US) Spasticity Treatment Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Spasticity Treatment Market Revenues & Volume, By Baclofen, 2021- 2031F |
6.3.3 United States (US) Spasticity Treatment Market Revenues & Volume, By Dantrolene Sodium, 2021- 2031F |
6.3.4 United States (US) Spasticity Treatment Market Revenues & Volume, By Gabapentin, 2021- 2031F |
6.3.5 United States (US) Spasticity Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Spasticity Treatment Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Spasticity Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 United States (US) Spasticity Treatment Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.4.4 United States (US) Spasticity Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) Spasticity Treatment Market, By Indication |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Spasticity Treatment Market Revenues & Volume, By Multiple Sclerosis (MS), 2021- 2031F |
6.5.3 United States (US) Spasticity Treatment Market Revenues & Volume, By Cerebral Palsy (CP), 2021- 2031F |
6.5.4 United States (US) Spasticity Treatment Market Revenues & Volume, By Traumatic Brain Injury (TBI), 2021- 2031F |
6.5.5 United States (US) Spasticity Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United States (US) Spasticity Treatment Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Spasticity Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 United States (US) Spasticity Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 United States (US) Spasticity Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.7 United States (US) Spasticity Treatment Market, By End-Users |
6.7.1 Overview and Analysis |
6.7.2 United States (US) Spasticity Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.7.3 United States (US) Spasticity Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.7.4 United States (US) Spasticity Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 United States (US) Spasticity Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Spasticity Treatment Market Import-Export Trade Statistics |
7.1 United States (US) Spasticity Treatment Market Export to Major Countries |
7.2 United States (US) Spasticity Treatment Market Imports from Major Countries |
8 United States (US) Spasticity Treatment Market Key Performance Indicators |
8.1 Patient satisfaction with spasticity treatment outcomes |
8.2 Number of healthcare providers offering spasticity treatment services |
8.3 Adoption rate of new spasticity treatment technologies |
8.4 Average wait times for spasticity treatment appointments |
8.5 Number of clinical trials for spasticity treatment options |
9 United States (US) Spasticity Treatment Market - Opportunity Assessment |
9.1 United States (US) Spasticity Treatment Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.2 United States (US) Spasticity Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 United States (US) Spasticity Treatment Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 United States (US) Spasticity Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 United States (US) Spasticity Treatment Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.6 United States (US) Spasticity Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.7 United States (US) Spasticity Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 United States (US) Spasticity Treatment Market - Competitive Landscape |
10.1 United States (US) Spasticity Treatment Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Spasticity Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here